<DOC>
	<DOC>NCT02515864</DOC>
	<brief_summary>A Placebo-controlled, Four Way Crossover Study to Investigate the Effect on QT/QTc Interval of a Single Dose of FYU-981, Compared with Placebo, Using Moxifloxacin as a Positive Control, in Healthy Male and Female Volunteers.</brief_summary>
	<brief_title>Clinical Pharmacology of FYU-981 (Effect on QT/QTc Interval)</brief_title>
	<detailed_description />
	<mesh_term>Moxifloxacin</mesh_term>
	<mesh_term>Fluoroquinolones</mesh_term>
	<mesh_term>Norgestimate, ethinyl estradiol drug combination</mesh_term>
	<criteria>Japanese adult subjects Body mass index: &gt;=18.5 and &lt;27.5 Subjects with any disease or any history of diseases that might be unsuitable for participation in the clinical study</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Male and Female Volunteers</keyword>
</DOC>